SCHEMBL3484853

SCHEMBL3484853

CC(c1ccc(C(=O)O)cc1)C(C=O)CCc1ccc(C(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 2/20 0.42
RARB P10826 6/20 0.42
RARA P10276 1/20 0.40
MAPT P10636 1/20 0.40
MTOR P42345 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
HPGD P15428 1/20 0.39
DPP4 P27487 1/20 0.39
HSP90AA1 P07900 1/20 0.38
ACACB O00763 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3484839 0.88 RXRA (0.38) RXRARXRBKMT2AMEN1HTT
SCHEMBL3484563 0.78 RXRA (0.44) RXRARXRBKMT2AMEN1HTT
SCHEMBL2160458 0.76 ALDH1A1 (0.47) KMT2AMEN1HTTSMN1; SMN2ALDH1A1
SCHEMBL104594 0.76 GRIN2D (0.57) RXRARXRBKMT2AMEN1HTT
SCHEMBL10629555 0.74 RXRA (0.57) RXRARXRBKMT2AMEN1SMN1; SMN2
SCHEMBL15569203 0.73 ALDH1A1 (0.44) KMT2AMEN1HTTSMN1; SMN2ALDH1A1
SCHEMBL31192242 0.73 TSHR (0.60) RXRARXRBKMT2ASMN1; SMN2ALDH1A1
SCHEMBL14720935 0.73 ALDH1A1 (0.52) RXRARXRBKMT2AMEN1HTT
SCHEMBL825507 0.73 ALDH1A1 (0.52) RXRARXRBKMT2AMEN1HTT
SCHEMBL2494105 0.72 ANPEP (0.46) KMT2AMEN1HTTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609727-B2 Dicarboxylic acid derivatives and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-12-17 US disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use PC, SLC25A1, GOT2 RXRA 501/4885RXRB 700/4885KMT2A 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.